Similar Items: Role of glycogen synthase kinase 3 (GSK-3) and its substrate proteins in the development of cardiomyopathy associated with obesity and insulin resistance
- The role of glycogen synthase kinase-3 (GSK-3) protein in the development of myocardial hypertrophy in a rat model of diet induced obesity and insulin resistance
- Design and synthesis of benzazole ureas as proposed irreversible GSK-3β inhibitors
- Design, synthesis and biological activity studies of 1-aryl-3-(4-methoxybenzyl)ureas as proposed irreversible GSK-3 inhibitors in Alzheimer’s disease therapeutic development
- The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells
- The regulatory design of glycogen metabolism in mammalian skeletal muscle
- Mutational analysis of genes involved in glycogen degradation in Escherichia coli
Author: Huisamen, Barbara
- An investigation into the importance of the ATM protein in the myocardial pathology associated with insulin resistance and type 2 diabetes
- Aspalathus linearis as a possible SGLT2 inhibitor - its effects on myocardial mitochondria.
- Role of glycogen synthase kinase 3 (GSK-3) and its substrate proteins in the development of cardiomyopathy associated with obesity and insulin resistance
- The anti-diabetic and insulin sensitizing potential of a watery extract of Agathosma tested in rat models of type 1 and type 2 diabetes
- A study of the early changes in hearts from diet-induced obese rats that may lead to cardiac dysfunction
- ATM Expression in peripheral blood mononuclear cells as a biomarker of insulin resistance